Major shareholder announcement – Swedbank Robur Fonder AB
ANNOUNCEMENT NO. 259
Major shareholder announcement
Major shareholder announcement – Swedbank Robur Fonder AB
Pursuant to Section 38 of the Danish Capital Markets Act, it is hereby announced that Swedbank Robur Fonder AB has informed ChemoMetec A/S that Swedbank Robur Fonder AB on 2 April 2024, decreased its holding of shares and voting rights to below 5% of the total share capital and voting rights in ChemoMetec A/S.
Additional information
Niels Høy Nielsen, CFO
Telephone (+45) 2551 8724
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies, such as Novartis, Novo Nordisk, H. Lundbeck, Merck, AstraZeneca and Johnson & Johnson.
ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For more information, go to www.chemometec.com
